First Allied Advisory Services’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$549K Sell
3,386
-384
-10% -$62.4K 0.02% 665
2020
Q2
$614K Buy
+3,770
New +$573K 0.02% 577
2018
Q1
Sell
-434
Closed -$53K 1185
2017
Q4
$53K Sell
434
-1,185
-73% -$151K ﹤0.01% 1293
2017
Q3
$217K Hold
1,619
0.01% 977
2017
Q2
$204K Buy
+1,619
New +$195K 0.01% 1026
2016
Q4
Sell
-2,869
Closed -$331K 1100
2016
Q3
$331K Buy
2,869
+100
+4% +$11.4K 0.02% 706
2016
Q2
$283K Sell
2,769
-65
-2% -$6.93K 0.02% 764
2016
Q1
$293K Hold
2,834
0.02% 751
2015
Q4
$360K Hold
2,834
0.02% 705
2015
Q3
$323K Sell
2,834
-405
-13% -$53.6K 0.02% 704
2015
Q2
$435K Sell
3,239
-25
-0.8% -$3.32K 0.02% 664
2015
Q1
$422K Buy
+3,264
New +$410K 0.03% 632
2014
Q4
Sell
-1,910
Closed -$204K 1037
2014
Q3
$204K Buy
+1,910
New +$193K 0.02% 914
2014
Q2
Sell
-2,533
Closed -$226K 1010
2014
Q1
$226K Sell
2,533
-422
-14% -$41K 0.02% 841
2013
Q4
$257K Buy
+2,955
New +$247K 0.02% 732

Other funds holding BBH

First Allied Advisory Services's BBH Position: Q3 2020 in Review

First Allied Advisory Services reduced its VanEck Biotech ETF (BBH) stake by 10% in Q3 2020, selling an estimated $62.4K and leaving 3,386 shares worth $549K. The position accounts for 0.02% of the portfolio, ranked #665.

First Allied Advisory Services first reported a position in BBH in Q4 2013 and has held it in 15 quarters since. The position peaked at $614K in Q2 2020. 101 funds tracked by Wall St. Rank hold BBH as of Q3 2020.

  • First Allied Advisory Services held 3,386 shares of VanEck Biotech ETF worth $549K as of Q3 2020.
  • First Allied Advisory Services sold 384 VanEck Biotech ETF shares in Q3 2020, an estimated $62.4K.
  • VanEck Biotech ETF made up 0.02% of First Allied Advisory Services's portfolio in Q3 2020, its #665 holding.
  • First Allied Advisory Services first reported a position in VanEck Biotech ETF in Q4 2013 and has held it in 15 quarters since.
  • First Allied Advisory Services's VanEck Biotech ETF position peaked at $614K in Q2 2020.
  • 101 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.